• Skip to primary navigation
  • Skip to main content

Highlights:

Read more
  • Careers
  • Support
  • Contact Us
AMRA Medical

AMRA Medical

Insights Within

  • Focus Areas
  • Our Services

      Research Services

      Unlock breakthroughs and power your clinical trials by implementing our research biomarkers to maximize your trial’s success and de-risk the drug development lifecycle. Read more

      Imaging Biomarkers
      MRI-based fat and muscle analysis measures for drug development teams.
      Insights Biomarkers
      Advanced analysis—descriptive, functionally-relevant fat and muscle assessment methodologies.

      Clinical Services

      Our clinical biomarkers provide your practice with easy-to-understand insights that are personalized and informative for each and every patient. Read more

      AMRA® BCP Scan
      Understand your patient’s fat and muscle composition using MRI-based measurements within health and wellness.
      AMRA® MAsS Scan
      Learn more about your patient’s muscle quality using our Muscle Assessment Score

      Services Based on Knowledge

      Read publications, insights articles and view insightful webinars.

      Insights Article

      Revealing the true impact of drug therapies for metabolic diseases through weight-invariant fat distribution assessment using AMRA’s Z-Scores

      Publication

      Evaluating the prevalence and severity of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus in primary care

      Explore more at our Knowledge Hub →

  • Science

      Science

      AMRA is on the forefront of precision medicine—providing body composition and medical insights driven by our digital health platform, team of experts, and ability to develop MRI biomarkers suitable for both clinical practice and research.

      Read more →

      What We Do
      We analyze MRI to classify and quantify muscle and fat with unprecedented accuracy and precision.
      How We Do It
      Our process of imaging technology and a massive reference database for fat and muscle composition.
      Why It Matters
      Our data guide decision-making—impacting your clinical trials and patient’s lives.
      Technology
      We’ve developed a patented, automated method for classifying and quantifying fat and muscle groups.
  • Knowledge Hub
  • About

      Company

      Our Story
      Read the story of AMRA—how it all started in academic research and grew into a science-driven partner helping researchers see what truly matters.
      Our Team
      At AMRA Medical, our work is powered by passionate people committed to advancing science and clinical outcomes. If you’re driven by curiosity, innovation, and impact, we’d love to meet you.
      Investors
      Our investors share our vision for advancing healthcare through deeper insights into the human body. Their expertise and perspective help us accelerate innovation, expand our global reach and turn that shared ambition into lasting impact.
      News
      Browse the latest updates from AMRA, including company news and press releases, recent research highlights, and stories showcasing ground-breaking health informatics innovation.
      Events
      Explore our event schedule below to see where we’re engaging with researchers, clinicians, industry partners, and other key stakeholders in order to drive progress.
      Media Kit
      AMRA’s Media Kit provides access to essential materials about AMRA, including relevant company information and useful brand assets.

      About AMRA

      AMRA Medical is a global leader in health informatics, pioneering fat and muscle analysis with proprietary MRI-based technologies. Our gold-standard platform delivers precise biomarkers, offering a deeper understanding of metabolic and musculoskeletal health. AMRA supports data-driven decision-making in research and clinical care through standardized, cloud-based workflows—enabling actionable insights from early discovery to clinical outcomes.

      Read more →

  • Get Started

Voiant Announces Strategic Partnership with AMRA Medical to Expand Advanced Imaging Biomarkers for Obesity and Metabolic Disease Clinical Trials

Collaboration combines AMRA's validated MRI-based body composition analytics with Voiant's specialized imaging expertise to advance obesity clinical trial endpoints beyond traditional weight-based measures.

November 12, 2026
  • Twitter
  • Facebook
  • LinkedIn

WALTHAM, Massachusetts, USA, November 12, 2026 – Voiant, an industry-leading clinical trial imaging solutions provider, is pleased to announce a strategic partnership with AMRA Medical, a global leader in validated quantitative MRI biomarkers for body composition analysis. The collaboration addresses the growing demand for advanced imaging biomarkers in obesity and metabolic disease clinical research.

As obesity drug development moves beyond traditional measures of weight loss, pharmaceutical sponsors increasingly need to understand how treatments affect fat distribution, muscle composition, and overall metabolic health. Through this partnership, AMRA’s quantitative MRI biomarkers provide pharmaceutical sponsors deeper insights into treatment-related changes, supporting more informed clinical development decisions. Combined with Voiant’s specialized clinical trial imaging expertise, sponsors gain a comprehensive solution to evaluate therapeutic impact throughout the trial life cycle.

AMRA’s quantitative MRI biomarkers will be seamlessly integrated into Voiant Hub, Voiant’s AI-powered imaging platform. The partnership enables a unified workflow from image acquisition through quantitative analysis and reporting, streamlining access to body composition imaging endpoints without added operational complexity.

Building on Voiant’s recent expansion into obesity and metabolic disease research, Voiant’s imaging CRO solutions are designed to eliminate fragmentation through an endpoint-driven approach that brings together advanced quantitative biomarkers, multimodality imaging capabilities, scientific expertise, and regulatory-ready infrastructure within a centralized clinical trial framework.

Olof Dahlqvist Leinhard, Chief Executive Officer at AMRA, stated:
“The future of obesity drug development requires a more complete understanding of how treatments affect fat and muscle, not just body weight. By combining AMRA’s advanced body composition biomarkers with Voiant’s clinical trial imaging capabilities, we are helping sponsors generate more meaningful evidence, better understand treatment response, and explore opportunities to differentiate emerging therapies.”

AMRA’s quantitative MRI technology delivers objective, standardized measurements of visceral and subcutaneous adipose tissue, liver fat, muscle volume, and muscle fat infiltration. These biomarkers provide insights beyond body weight and BMI, helping researchers characterize the quality of weight loss, assess changes in fat and muscle, and better understand treatment response. Additionally, AMRA’s unique Muscle and Body Fat Z-Scores enable a deeper level of understanding and personalization that traditional metrics or direct imaging biomarkers simply cannot achieve.

Together, Voiant and AMRA will expand access to advanced imaging biomarkers, enabling pharmaceutical sponsors to gain a more comprehensive understanding of treatment effects and explore therapeutic differentiation across obesity, MASH, diabetes, and other cardiometabolic development programs.

Jim Primerano, Chief Executive Officer at Voiant, commented:
“Obesity and metabolic disease research is rapidly evolving, creating demand for more sophisticated ways to understand treatment effects beyond traditional weight-based measures. Our partnership with AMRA strengthens Voiant’s ability to deliver advanced body composition endpoints within the integrated imaging, scientific, and operational framework sponsors already rely on. Together, we’re helping bring the next generation of obesity endpoints into clinical development.”

This partnership is being announced ahead of ObesityWeek® 2026, where Voiant will be exhibiting at Booth #638. Visit our team to learn how Voiant and AMRA are supporting sponsors to move beyond BMI through quantitative body composition biomarkers, advanced imaging endpoints, and clinically meaningful measures of treatment response.

About Voiant
Voiant is the industry leading clinical trial imaging solutions provider with unparalleled scientific and clinical domain expertise — providing biopharmaceutical companies the shortest path to the highest quality imaging endpoint data. Voiant Hub is our built for purpose AI-powered platform, enabling us to manage the entire clinical imaging process while providing site management, as well as full transparency to sponsors every step of the way from image upload, quality control, read & analysis to delivering high quality clinical endpoints with unrivaled speed and precision.

About AMRA Medical
AMRA Medical is a global leader in health informatics, pioneering the field of fat and muscle analysis with proprietary, MRI-based technologies. Our gold-standard platform delivers highly precise and standardized biomarkers, providing an advanced understanding of metabolic and musculoskeletal health that surpasses conventional measures of muscle and fat. These insights play a critical role in optimizing clinical trial design, improving endpoint selection, and supporting data-driven decision-making in both research and clinical practice.

Contact
Vivian Nguyen
+1.888.963.3742
info@voiantclinical.com

Melinda Perjons
+46 13 16 26 00
info@amramedical.com

All posts
  • Twitter
  • Facebook
  • LinkedIn

Get all the latest updates from AMRA

Valuable insights and exclusive updates from AMRA Medical on the MRI-based fat and muscle analytics shaping research and clinical care, delivered straight to your inbox.

Footer icon
  • Our Services
    • Research Services
    • Clinical Services
  • About Us
    • Our Team
    • Careers
    • News
    • Media Kit
  • Knowledge Hub
    • Insights Articles
    • Webinar
    • Publications
© 2026 AMRA Medical AB
  • Data Privacy Policy
  • Cookie Policy
AMRA Medical
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
AMRA Medical
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}